A Randomized, Prospective Study Measuring Outcomes after Antibiotic Therapy Intervention by a Multidisciplinary Consult Team
Patient Care Team
Length of Stay
Communicable Diseases
Anti-Bacterial Agents
3. Good health
Survival Rate
03 medical and health sciences
Treatment Outcome
0302 clinical medicine
Cost of Illness
Humans
Prospective Studies
Economics, Hospital
Infusions, Intravenous
Aged
DOI:
10.1592/phco.19.18.1369.30898
Publication Date:
2004-04-27T09:52:53Z
AUTHORS (4)
ABSTRACT
Our aim was to identify financial and outcome benefits of therapeutic intervention by a multidisciplinary antimicrobial treatment team composed of pharmacists, a clinical microbiologist, and an infectious disease specialist. Of 252 consecutive inpatients receiving suboptimal intravenous antibiotics identified by the clinical pharmacist, 127 were prospectively randomized to intervention and 125 to a control group. The groups were similar with regard to severity of illness, infection type, and time from admission to randomization. Physicians received timely, detailed reviews of relevant microbiologic and clinical data with recommendations of possible optimal antibiotic choices, dosages, and rationales. Median length of stay after randomization for control and intervention groups was 9.0 days and 5.7 days, respectively (3.3‐day difference, p=0.0001). Fifteen (12.0%) and eight patients (6.3%), respectively, died, although the time‐specific mortality risk was not significantly different when length of postrandomization follow‐up and time to death were taken into account. Physician acceptance of suggestions was 89%. Median patient charges for radiology, laboratory, pharmacy, and room were reduced by $4404/intervention, and median hospital costs were reduced by $2642/intervention. A multidisciplinary antimicrobial therapy team can be a useful information source for physicians, improve outcomes in hospitalized patients receiving intravenous antimicrobials, and result in substantial cost savings.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (25)
CITATIONS (98)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....